Gradiant Corporation
Financials
Valuation Metrics
Gradiant Corporation's Market Cap is ₩1266B. At end of 2025 it was ₩1275B. Ranked #1068 of 2,405 in KR market (top 44%), #547 of 1,627 on KOSDAQ (top 34%), #26 of 47 in Consumer Discretionary Distribution & Retail (top 55%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 126.60B KRW | KR#1,068/2,405 Sec#26/47 |
| Revenue | 3.43T KRW | KR#181/2,405 Sec#7/47 |
| Net Income | -2.01B KRW | KR—/2,405 Sec—/47 |
| Total Assets | 1.86T KRW | KR#314/2,405 Sec#10/47 |
| Net Assets | 724.62B KRW | KR#381/2,405 Sec#14/47 |
| Employees | 63 | KR#1,932/2,405 Sec#34/47 |
| Value | ||
| P/B | 0.17x | KR#109/2,405 Sec#5/47 |
| P/S | 0.04x | KR#15/2,405 Sec#1/47 |
| FCF Yield | -7.46% | KR—/2,405 Sec—/47 |
| Profitability | ||
| ROE | -0.28% | KR#1,563/2,405 Sec#29/47 |
| ROA | -0.11% | KR#1,557/2,405 Sec#29/47 |
| Op. Margin | -0.19% | KR#1,613/2,405 Sec#35/47 |
| Revenue Growth | 11.10% | KR#844/2,405 Sec#12/47 |
| Financial Health | ||
| Debt Ratio | 156.10% | KR#1,930/2,405 Sec#35/47 |
| Total Debt | 182.52B KRW | KR#540/2,405 Sec#18/47 |
| FCF | -9.44B KRW | KR#1,682/2,405 Sec#32/47 |
| Cash | 132.02B KRW | KR#382/2,405 Sec#8/47 |
| Current Ratio | 1.12x | KR#1,573/2,405 Sec#27/47 |
| Dividend | ||
| Div. Yield | 1.76% | KR#977/2,405 Sec#23/47 |
| Div. Growth | 0.00% | KR—/2,405 Sec—/47 |
| Performance | ||
| 1Y Return | -11.14% | KR#818/2,405 Sec#12/47 |
| 1M Return | -2.24% | KR#474/2,405 Sec#12/47 |
| From 52W High | -25.95% | KR#311/2,405 Sec#8/47 |
| 1Y MDD | -45.71% | KR#769/2,405 Sec#19/47 |
| Trading | ||
| Volume | 20,583 shares | KR#1,466/2,405 Sec#24/47 |
| Trading Value | 233.8M KRW | KR#1,066/2,405 Sec#18/47 |
| Foreign Own. | 3.23% | KR#1,217/2,405 Sec#25/47 |
| Per Share | ||
| EPS | -180 KRW | KR—/2,405 Sec—/47 |
| BPS | 64,848 KRW | KR#213/2,405 Sec#7/47 |
Company Info
Gradient, established in 1997 and listed on KOSDAQ in 1999, entered the healthcare industry in 2014 and completed the incorporation and absorption merger of subsidiaries in 2025. It provides comprehensive management for affiliated companies, B2B e-commerce for industrial goods, bio-healthcare business (including development, research, and distribution of pharmaceuticals and medical supplies), and integrated logistics agency services. Through its health functional food brand Radiewell and inner beauty brand Leanfit, the company focuses on selecting premium ingredients and developing products, pursuing global business expansion. Gradient is headquartered in Gangnam-gu, Seoul.